Dr. Headland leads Biology at Sound Biologics, overseeing drug development programs in neurology, autoimmunity, and oncology. She manages a team advancing multispecific antibodies and brain-shuttle technologies, with responsibility for IND-enabling programs and external collaborations.

Previously, Dr. Headland served as Associate Director of Myeloid Biology at Immunai and held scientific leadership roles at Spring Discovery, Alector, and Genentech. Her work has contributed to multiple patents and publications in Science Translational Medicine, Cell Reports, and other scientific journals.

Dr. Headland earned her Ph.D. in Biochemical Pharmacology from Queen Mary University of London and completed a postdoctoral fellowship at the University of California, San Francisco as an Arthritis Research UK Foundation Fellow.